Abstract
Clinical research involving children with hypertension poses unique opportunities and challenges. In particular, the complications of hypertension accrue over the course of many years and are relatively infrequent, so studies need to be large and long term to identify clinically important end points. Despite the challenges, an evidence base is beginning to amass that should eventually answer many of the relevant questions. We now have a good idea of how blood pressure tracks from the beginnings of life to early adulthood and an understanding of the relative importance of different risk factors. This chapter aims to inform the reader of different study designs as they apply to pediatric hypertension, and how these can be applied to answer specific questions of clinical importance. We also discuss the strengths and weaknesses of different study designs, and the results of some particularly impactful trials are discussed. Recent advances in study design and epidemiology are covered, with a focus on the potential role of data sharing.
References
Altman DG (2000) Statistics in medical journals: some recent trends. Stat Med 19:3275–3289
Antman EM, Lau J, Kupelnick B et al (1992) A comparison of results of meta-analyses of randomized control trials and recommendations of clinical experts. Treatments for myocardial infarction. JAMA 268:240–248
Badve SV, Palmer SC, Strippoli GFM, et al (2016) The validity of left ventricular mass as a surrogate end point for all-cause and cardiovascular mortality outcomes in people with CKD: a systematic review and meta-analysis. Am J Kidney Dis 68:1–10.
Bao W, Threefoot SA, Srinivasan SR, Berenson GS (1995) Essential hypertension predicted by tracking of elevated blood pressure from childhood to adulthood: the Bogalusa heart study. Am J Hypertens 8:657–665
Barnes DE, Bero L (1998) Why review articles on the health effects of passive smoking reach different conclusions. JAMA 279:1566–1570
Begley CG, Ellis LM (2012) Drug development: raise standards for preclinical cancer research. Nature 483:531–533
Bhurke S, Cook A, Tallant A et al (2015) Using systematic reviews to inform NIHR HTA trial planning and design: a retrospective cohort. BMC Med Res Methodol 15:108
Bierer BE, Li R, Barnes M, Sim I (2016) A global, neutral platform for sharing trial data. N Engl J Med 374:2411–2413
Bossuyt PM, Irwig L, Craig J, Glasziou P (2006) Comparative accuracy: assessing new tests against existing diagnostic pathways. BMJ 332:1089–1092
Caldwell PH, Murphy SB, Butow PN, Craig JC (2004) Clinical trials in children. Lancet 364:803–811
Chalmers I (2005) Academia’s failure to support systematic reviews. Lancet 365:469
Chalmers I, Bracken MB, Djulbegovic B et al (2014) How to increase value and reduce waste when research priorities are set. Lancet 383:156–165
Chan A-W, Song F, Vickers A et al (2014) Increasing value and reducing waste: addressing inaccessible research. Lancet 383:257–266
Chen W, Srinivasan SR, Li S et al (2007) Clustering of long-term trends in metabolic syndrome variables from childhood to adulthood in Blacks and Whites: the Bogalusa Heart Study. Am J Epidemiol 166:527–533
Chiolero A, Bovet P, Paradis G (2013) Screening for elevated blood pressure in children and adolescents: a critical appraisal. JAMA Pediatr 167:1–8
Ciani O, Buyse M, Garside R et al (2013) Comparison of treatment effect sizes associated with surrogate and final patient relevant outcomes in randomised controlled trials: meta-epidemiological. BMJ 457:1–12
Clarke M, Hopewell S, Chalmers I (2010) Clinical trials should begin and end with systematic reviews of relevant evidence: 12 years and waiting. Lancet 376:20–21
Cordoba G, Schwartz L, Woloshin S et al (2010) Definition, reporting, and interpretation of composite outcomes in clinical trials: systematic review. BMJ 341:c3920
Crowley P (2000) Prophylactic corticosteroids for preterm birth. Cochrane Database Syst (2):CD000065
Davey C, Aiken AM, Hayes RJ, Hargreaves JR (2015) Re-analysis of health and educational impacts of a school-based deworming programme in western Kenya: a statistical replication of a cluster quasi-randomized stepped-wedge trial. Int J Epidemiol 44:1581–1592
Dechartres A, Trinquart L, Boutron I, Ravaud P (2013) Influence of trial sample size on treatment effect estimates: meta-epidemiological study. BMJ 346:f2304
Dickersin K (2012) The evolution of trial registries and their use to assess the clinical trial enterprise. JAMA 307:1861–1864
Din-Dzietham R, Liu Y, Bielo MV, Shamsa F (2007) High blood pressure trends in children and adolescents in national surveys, 1963 to 2002. Circulation 116:1488–1496
Doshi P (2015) No correction, no retraction, no apology, no comment: paroxetine trial reanalysis raises questions about institutional responsibility. BMJ 4629:h4629
Dwyer T, Sun C, Magnussen CG et al (2013) Cohort profile: the international childhood cardiovascular cohort (i3c) consortium. Int J Epidemiol 42:86–96
Ebrahim S, Sohani ZN, Montoya L et al (2014) Reanalyses of randomized clinical trial data. JAMA 312:1024–1032
Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629–634
Eisenstein EL, Collins R, Cracknell BS et al (2008) Sensible approaches for reducing clinical trial costs. Clin Trials 5:75–84
Emanuel EJ (2000) What make clinical research ethical? JAMA 283:2701–2711
Fanelli D (2009) How many scientists fabricate and falsify research? A systematic review and meta-analysis of survey data. PLoS One 4:e5738
Fergusson D, Aaron SD, Guyatt G, Hébert P (2002) Post-randomisation exclusions: the intention to treat principle and excluding patients from analysis. BMJ 325:652–654
Fitzmaurice GM, Laird NM, Ware JH (2011) Applied longitudinal analysis. Wiley, Hoboken
Fixler DE, Laird WP (1983) Validity of mass blood pressure screening in children. Pediatrics 72:459–463
Fontanarosa PB, Rennie D, DeAngelis CD (2004) Postmarketing surveillance – lack of vigilance, lack of trust. JAMA 292:2647–2650
Grimes DA, Schulz KF (2012) False alarms and pseudo-epidemics: the limitations of observational epidemiology. Obstet Gynecol 120:920–927
Haug CJ (2016) From patient to patient — sharing the data from clinical trials. N Engl J Med 374:2409–2411
Higgins JPT, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327:557–560
Huang RC, Burrows S, Mori TA et al (2015) Life course adiposity and blood pressure between birth and 17 years old. Am J Hypertens 28:1056–1063
Impicciatore P, Choonara I, Clarkson A et al (2001) Incidence of adverse drug reactions in paediatric in/out-patients: a systematic review and meta-analysis of prospective studies. Br J Clin Pharmacol 52:77–83
Institute of medicine (2015) Sharing clinical trial data. National Academies Press, Washington, D.C.
Jadad AR, Moher M, Browman GP et al (2000) Systematic reviews and meta-analyses on treatment of asthma: critical evaluation. BMJ 320:537–540
Jefferson T, Doshi P (2014) Multisystem failure: the story of anti-influenza drugs. BMJ 348:g2263
Johnson CL, Paulose-Ram R, Ogden CL et al (2013) National health and nutrition examination survey: analytic guidelines, 1999–2010. Vital Health Stat 2:1999–2010
Jørgensen AW, Hilden J, Gøtzsche PC (2006) Cochrane reviews compared with industry supported meta-analyses and other meta-analyses of the same drugs: systematic review. BMJ 333:782
Juhola J, Magnussen CG, Viikari JS et al (2011) Tracking of serum lipid levels, blood pressure, and body mass index from childhood to adulthood: the cardiovascular risk in young finns study. J Pediatr 159:584–590
Juhola J, Magnussen CG, Berenson GS et al (2013) Combined effects of child and adult elevated blood pressure on subclinical atherosclerosis: the international childhood cardiovascular cohort consortium. Circulation 128(3):217–224
Kagura J, Adair LS, Musa MG et al (2015) Blood pressure tracking in urban black South African children: birth to twenty cohort. BMC Pediatr 15:78
Kim C, Prasad V (2015) Cancer drugs approved on the basis of a surrogate end point and subsequent overall survival. JAMA 175:1992–1994
Kjaergard LL, Villumsen J, Gluud C (2001) Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses. Ann Intern Med 135:982–989
Lau J, Ioannidis JPA, Terrin N et al (2006) The case of the misleading funnel plot. BMJ 333:597–600
Lauer RM, Clarke WR (1989) Childhood risk factors for high adult blood pressure: the Muscatine Study. Pediatrics 84:633–641
Le Noury J, Nardo JM, Healy D et al (2015) Restoring Study 329: efficacy and harms of paroxetine and imipramine in treatment of major depression in adolescence. BMJ 351:h4320
Leeflang MMG, Rutjes AWS, Reitsma JB et al (2013) Variation of a test’s sensitivity and specificity with disease prevalence. Can Med Assoc J 185:E537–E544
Levy PS, Lemeshow S (2008) Sampling of populations. Wiley, Hoboken
Lim SS, Vos T, Flaxman AD et al (2012) A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380:2224–2260
Little RJ, D’Agostino R, Cohen ML et al (2012) The prevention and treatment of missing data in clinical trials. N Engl J Med 367:1355–1360
Lo T, Malaga-Dieguez L, Trachtman H (2014) U.S. preventive services task force recommendation and pediatric hypertension screening: dereliction of duty or call to arms? J Clin Hypertens 16:342–343
Lurbe E, Agabiti-Rosei E, Cruickshank JK et al (2016) 2016 European Society of Hypertension guidelines for the management of high blood pressure in children and adolescents. J Hypertens 34:1887–1920
Martinson BC, Anderson MS, de Vries R (2005) Scientists behaving badly. Nature 435:737–738
Merson L, Gaye O, Guerin PJ (2016) Avoiding data dumpsters — toward equitable and useful data sharing. N Engl J Med 374:2414–2415
Miller H (1973) Plan and operation of the health and nutrition examination survey: United States-1971-1973. DHEW publication no (PHS)-Dept. of Health, Education, and Welfare (USA)
Moher D, Liberati A, Tetzlaff J et al (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6:e1000097
Moher D, Tetzlaff J, Tricco AC et al (2007) Epidemiology and reporting characteristics of systematic reviews. PLoS Med 4:447–455
Moyer VA, USPSTF (2014) Screening for primary hypertension in children and adolescents: U.S. preventative services task force recommendation statement. Ann Intern Med 160:613–620
Pletcher MJ, Lo B, Grady D (2014) Informed consent in randomized quality improvement trials: a critical barrier for learning health systems. JAMA Intern Med 174:668–670
Porta N, Bonet C, Cobo E (2007) Discordance between reported intention-to-treat and per protocol analyses. J Clin Epidemiol 60:663–669
Prinz F, Schlange T, Asadullah K (2011) Believe it or not: how much can we rely on published data on potential drug targets? Nat Rev Drug Discov 10:712
Pyörälä K, Salonen JT, Valkonen T (1985) Trends in coronary heart disease mortality and morbidity and related factors in Finland. Cardiology 72:35–51
Rademacher ER, Jacobs DR, Moran A et al (2009) Relation of blood pressure and body mass index during childhood to cardiovascular risk factor levels in young adults. J Hypertens 27:1766–1774
Raitakari OT, Juonala M, Rönnemaa T et al (2008) Cohort profile: the cardiovascular risk in young Finns study. Int J Epidemiol 37:1220–1226
Rapsomaniki E, Timmis A, George J et al (2014) Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1·25 million people. Lancet 383:1899–1911
Reitsma JB, Rutjes AWS, Khan KS et al (2009) A review of solutions for diagnostic accuracy studies with an imperfect or missing reference standard. J Clin Epidemiol 62:797–806
Rosner B, Cook NR, Daniels S, Falkner B (2013) Childhood blood pressure trends and risk factors for high blood pressure: the NHANES experience 1988-2008. Hypertension 62:247–254
Rothman KJ (1990) No adjustments are needed for multiple comparisons. Epidemiology 1:43–46
Saha C, Jones MP (2009) Bias in the last observation carried forward method under informative dropout. J Stat Plan Inference 139:246–255
Samuels J, Bell C, Flynn JT (2013) Screening children for high blood pressure: where the US preventive services task force went wrong. J Clin Hypertens 15:526–527
Schulz KF (1995) Subverting randomization in controlled trials. JAMA 274:1456–1458
Schulz KF, Chalmers I, Hayes RJ, Altman DG (1995) Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 273:408–412
Schulz KF, Grimes DA (2005) Multiplicity in randomised trials I: endpoints and treatments. Lancet 365:1591–1595
Shear CL, Burke GL, Freedman DS, Berenson GS (1986) Value of childhood blood pressure measurements and family history in predicting future blood pressure status: results from 8 years of follow-up in the Bogalusa Heart Study. Pediatrics 77:862–869
Simera I, Moher D, Hirst A et al (2010) Transparent and accurate reporting increases reliability, utility, and impact of your research: reporting guidelines and the EQUATOR Network. BMC Med 8:24
Staa TP, Goldacre B, Gulliford M et al (2012) Pragmatic randomised trials using routine electronic health records: putting them to the test. BMJ 344:e55
Stergiou GS, Nasothimiou E, Giovas P et al (2008) Diagnosis of hypertension in children and adolescents based on home versus ambulatory blood pressure monitoring. J Hypertens 26:1556–1562
Streptomycin in Tuberculosis Trials Committee (1948) Streptomycin treatment of pulmonary tuberculosis. BMJ 2:769–782
Sun SS, Grave GD, Siervogel RM et al (2007) Systolic blood pressure in childhood predicts hypertension and metabolic syndrome later in life. Pediatrics 119:237–246
Svensson S (2016) Surrogate outcomes in clinical trials. JAMA Intern Med, 173:611–612
Taichman DB, Backus J, Baethge C et al (2016) Sharing clinical trial data: a proposal from the international committee of medical journal editors. PLoS Med 13:e1001950
Theodore RF, Broadbent J, Nagin D et al (2015) Childhood to early-midlife systolic blood pressure trajectories. Hypertension 66:1108–1115
Thompson M (2014) Gaps in the evidence for screening children for hypertension to prevent adult cardiovascular disease-response to the editorial by Samuels and Colleagues. J Clin Hypertens 16:80–81
Thompson M, Dana T, Bougatsos C et al (2013) Screening for hypertension in children and adolescents to prevent cardiovascular disease. Pediatrics 131:490–525
Tong A, Samuel S, Zappitelli M et al (2016) Standardised outcomes in nephrology—children and adolescents (SONG-Kids): a protocol for establishing a core outcome set for children with chronic kidney disease. Trials 17:401
Turner EH, Matthews AM, Linardatos E, Tell RA, Rosenthal R (2008) Selective publication of antidepressant trials and its influence on apparent efficacy. New Eng J Med 358:252–260
Urbina EM, De Ferranti S, Steinberger J (2014) Observational studies may be more important than randomized clinical trials: weaknesses in us preventive services task force recommendation on blood pressure screening in youth. Hypertension 63:638–640
Van Spall HGC, Toren A, Kiss A, Fowler RA (2007) Eligibility criteria of randomized controlled trials published in high-impact general medical journals. JAMA 297:1233–1240
von Elm E, Altman DG, Egger M et al (2008) The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol 61:344–349
Voors AW, Foster TA, Frerichs RR et al (1976) Studies of blood pressures in children, ages 5-14 years, in a total biracial community: the Bogalusa Heart Study. Circulation 54:319–327
Wells G, Shea B, O’Connell D, et al (2012) The newcastle-ottawa scale (NOS) for assessing the quality if nonrandomized studies in meta-analyses. Available from http//www.ohri.ca/programs/clinical_epidemiology/oxford.asp. Accessed 10 Nov 2016
Whiting PF, Rutjes AWS, Westwood ME et al (2011) QUADAS-2: research and reporting methods accuracy studies. Ann Intern Med 155:529–536
Whiting PF, Rutjes AWS, Westwood ME, Mallett S (2013) A systematic review classifies sources of bias and variation in diagnostic test accuracy studies. J Clin Epidemiol 66:1093–1104
Woertman W, de Hoop E, Moerbeek M et al (2013) Stepped wedge designs could reduce the required sample size in cluster randomized trials. J Clin Epidemiol 66:752–758
Wood AM, White IR, Thompson SG (2004) Are missing outcome data adequately handled? A review of published randomized controlled trials in major medical journals. Clin Trials 1:368–376
Wühl E, Trivelli A, Picca S et al (2009) Strict blood-pressure control and progression of renal failure in children. N Engl J Med 361:1639–1650
Zarin DA, Tse T, Williams RJ, et al (2011) The ClinicalTrials.gov results database — update and key issues. N Engl J Med 364:852–860
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing AG
About this entry
Cite this entry
Larkins, N., Craig, J. (2016). Cohort Studies, Meta-analyses, and Clinical Trials in Childhood Hypertension. In: Flynn, J., Ingelfinger, J., Redwine, K. (eds) Pediatric Hypertension. Springer, Cham. https://doi.org/10.1007/978-3-319-31420-4_54-1
Download citation
DOI: https://doi.org/10.1007/978-3-319-31420-4_54-1
Received:
Accepted:
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-31420-4
Online ISBN: 978-3-319-31420-4
eBook Packages: Springer Reference MedicineReference Module Medicine
Publish with us
Chapter history
-
Latest
Cohort Studies, Meta-analyses, and Clinical Trials in Childhood Hypertension- Published:
- 17 March 2022
DOI: https://doi.org/10.1007/978-3-319-31420-4_54-2
-
Original
Cohort Studies, Meta-analyses, and Clinical Trials in Childhood Hypertension- Published:
- 23 December 2016
DOI: https://doi.org/10.1007/978-3-319-31420-4_54-1